Chinese Hepatology 2011 Issue 1 Progress in the diagnosis and treatment of overlap syndrome(AIH and PBC)

Progress in the diagnosis and treatment of overlap syndrome(AIH and PBC)
sun ying ; zuo guang ju ; li bao sen ; zou zheng sheng

..............page:73-75

da chang ai xi shi jun he xin sheng yin qiu jun zi fa xing fu mo yan 1 li
ji jin ling ; bao chun mei ; guo tong sheng

..............page:70

man xing yi xing gan yan he bing ren shen qi gan nei dan zhi yu ji zheng 1 li
shao ming ; xiao yu zhen

..............page:59

Guideline for the management of chronic hepatitis B

..............page:2-16

The role of hepatic enzymes in diagnosis of liver diseases
JIA Wen;YAO Guang-bi

..............page:75-77

The expression of RUNX3 in hepatic cell carcinoma and its relationship with clinical pathological parameters
LU Yan-hui;ZHENG Rui-dan;CHEN Jie;CHEN Bi-fen;LI Jian-guo;LIN Zhi-chuan

..............page:27-30

Immunosuppressant-induced HBV reactivation in rheumatic patients
TAN Jing;WEI Jin;ZHOU Jing-guo

..............page:78-80

shi jiu dui man xing yi xing gan yan cu fa gan xi bao ai wei xian yin su de ying xiang
liu yan wei ; guo xi ping

..............page:84-85

yi xing gan yan gan ying hua ban gan xue xi chong bing wu zhen yuan fa xing gan ai 1 li
xu jing ; yu le cheng ; he chang lun ; zhang ying ; li ping ; sheng yun feng ; hao kun yan ; shao

..............page:89-90

yi xue niao he fu bi bao kuai wei te shu biao xian qie afp zheng chang de gan xian ai 1 li
gu sheng wang ; jiang zhao rong ; sun yao yao ; hu da shan ; liu chun yan ; zhao zhi fen

..............page:90

Combination with nucleoside/tide analogues for the patients with chronic hepatitis B who had no response to failed to interferon alpha and nucleoside/tide analogue:a 5-year clinical course
XIAO Yang;LU Cheng-hong;JIANG Shan;PAN Hua-jiang;WANG Qi-liang;HU Xia;ZHANG Wen-jing;ZHENG Jin-li;ZHOU Yue-jin

..............page:23-26

ben bing tong niao zheng 1 li
li yun chang ; shao ming ; xiao yu zhen

..............page:26

en ti ka wei zhi liao yu man xing yi xing gan yan huan zhe wai zhou xue diao jie xing t xi bao de bian hua
song chun hui ; yang bin ; chen li ming ; zhang ji yuan

..............page:52-54

The genetic factors of drug-induced liver injury
SUN Li-na;ZHANG Xin-xin

..............page:68-70

gan rao su zhi liao bing xing gan yan gan ying hua liao xiao guan cha ji an quan xing
ou yang shan shan ; long xiang zhen ; hu li hua ; zhang ming ; wu wen qin

..............page:86-87

Tracing study on spontaneous HBV YMDD mutation in chronic HBV carriers
QU Jun-xiao;ZENG Qing-lei;LI Chun-xia;FENG Ji-hong;XU Guang-hua

..............page:17-19

la mi fu ding yu a de fu wei zuo jiao ti zhi liao shi dai chang qi gan ying hua lin chuang guan cha
jian guang fu ; sun wen feng ; chen zuo ; xie li ping

..............page:85-86

Causality assessment in drug-induced liver injury using a structured expert opinion prcess(SEOP): comparison to the Roussel-Uclaf causality assessment method(RUCAM)
YU Yue-cheng

..............page:60-61

gan tang yuan zhu ji bing 1 li
liu qian ; ding hong bing ; pan xing nan

..............page:16

The short-term prognostic value of the model for end stage liver disease including serum sodium in liver cirrhosis patients with esophageal-gastric varices bleeding(EGVB)
FANG Nian-fu;ZENG Jing;CHENG Fei;YU Xiao-yan;CHEN Min-yan;DING Yuan-jun;YU Shu-yu

..............page:20-22

xin xi dong tai

..............page:1,40,77,83,91-93

Increased heme oxygenase activity in splanchnic organs from cirrhotic rats
YANG Shu-ping;WANG Ji-yao;GUO Jin-sheng

..............page:45-47

kun ming di qu bing xing gan yan huan zhe ji yin fen xing ji qi lin chuang yi yi
lei hua ; dai jing yi ; bai bao li ; zhuang lin

..............page:48-49

Unsettled issues of nucleoside analogues in chronic hepatitis B treatment
MIAO Zheng-qiu

..............page:62

The characteristic and mechanism of angiogenesis in a mouse model of liver fibrosis
LU Jing;LU Xiong;TAO Yan-yan;ZHAO Zhi-min;LIU Cheng-hai

..............page:35-40

yi xing gan yan huan zhe t lin ba xi bao ya qun jian ce de lin chuang yi yi
bai liu jiang

..............page:87-88

Small interfering RNA targeting connective tissue growth factor inhibits rat liver fibrosis in vivo
XUE Miao;MAO Xiao-rong;CHEN Hong;YUE Wei

..............page:41-44

Management of anemia caused by Ribavirin treatment in hepatitis C
LUO Sheng-qiang

..............page:71-72

Progress in the treatment of liver fibrosis
WANG Wei-jing;XIE Qin

..............page:65-67

la mi fu ding jing zhi man xing yi xing gan yan huan zhe zhi liao ce lue zhuan jia yan tao hui ji yao
zuo xiao guang ; zhang wen hong

..............page:58-59

The dynamic mechanism of specific immune response in HBV infection
SUN Ran;YU Zu-jiang

..............page:80-82

zhong shi yao wu xing gan bing yan jiu de jin zhan
chen cheng wei

..............page:1

bai xi bao jie su -18 zhong liu huai si yin zi yu gan ai huan zhe yu hou de xiang guan xing
wang xiao yin ; zhu jin shui ; xu zhi peng ; zhou zhou ; zhang qiang ; da zuo

..............page:56-57

Pharmacogenetics of drug-induced liver injury
LAI Rong-tao;Xie Qin

..............page:63-65

xin fa ta ting dui gan ying hua huan zhe men mai xue liu ji gan xian wei hua zhi biao de ying xiang
zheng sheng ; liu hai ; yin fang ; xiao qiong zuo ; zhu wei mei ; wang jian gang ; yang lan yan ; guo zhi ping

..............page:50-52

gan zang ge duan gan xi bao nei hbv cccdna he hbv tdna shui ping fen bu
guo wen wen ; jiang jian ning ; su ming hua ; liu zhi hong ; liang yan xiu ; hu jia guang ; ge shan fei

..............page:54-56

The expression of KLF-6 in HCC and its effect on proliferation and apoptosis in HCC cell lines
LIANG Ming;LV Shu-lan;WANG Xiao-yan;LI Jing-yuan;ZHAO Yong-hua;KANG Peng;GAO Jie

..............page:31-34